4.4 Article

Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Medicinal

Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors

Marthe Soenksen et al.

Summary: Although arsenic has a history as a poison, it has gained reputation as a promising anticancer drug. Transitioning arsenic trioxide from bench to bedside poses challenges, which nanomedicine tools are proposed to address. Various materials as nanocarriers of arsenic trioxide have been examined to improve drug delivery.

MEDICINAL RESEARCH REVIEWS (2022)

Article Surgery

Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation

Sunyoung Lee et al.

Summary: In this study, surgical resection (SR) was found to be associated with a lower rate of early recurrence compared to radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) based on the risk of microvascular invasion (MVI). The predictive model developed in the study accurately predicted the risk of MVI in HCC patients with high accuracy, indicating that patients with MVI who underwent RFA were more prone to recurrence than those who underwent SR.

ANNALS OF SURGERY (2021)

Review Gastroenterology & Hepatology

Epidemiology of Hepatocellular Carcinoma

Katherine A. McGlynn et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major global health concern. While HBV and HCV remain important risk factors for HCC, efforts in vaccination and treatment are showing promise. However, the increasing prevalence of metabolic risk factors like obesity and diabetes, as well as other factors like excessive alcohol consumption, present ongoing challenges in the prevention of liver cancer.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Local and Regional Therapies for Hepatocellular Carcinoma

Roman Kloeckner et al.

HEPATOLOGY (2021)

Review Surgery

Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria A Systematic Review and Meta-analysis

Seong Wook Shin et al.

Summary: This study found that liver resection (LR) is more effective than local ablation therapies (such as RFA, MWA, and RFA plus TACE) in treating HCC within the Milan criteria. Specifically, LR has better 5-year recurrence-free survival and lower local recurrence rates compared to local ablation therapies.

ANNALS OF SURGERY (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Oncology

Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically

Xin Zhang et al.

Summary: Differentiation-inducing therapy using arsenic trioxide (ATO) was shown to effectively induce differentiation of hepatocellular carcinoma (HCC) cancer stem cells (CSCs) by downregulating CSC-related genes and suppressing tumorigenicity. Combinatorial treatment with ATO and 5-fluorouracil/cisplatin enhanced therapeutic effects through synergistic inhibition of the LIF/JAK1/STAT3 and NF-kB signaling pathways in HCC cells. These findings provide new insights for clinical treatment of HCC.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Oncology

Metabolic adaptation in hypoxia and cancer

Felipe Paredes et al.

Summary: The focus of cells' adaptation to hypoxia is the transcription factor HIF1α, which promotes tumor development by affecting cellular metabolism. In addition to hypoxia, metabolic inhibition also influences HIF1α stability and activity, promoting glycolytic metabolism in cancer cells to support growth and proliferation.

CANCER LETTERS (2021)

Article Biochemistry & Molecular Biology

Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1

Nan Lin et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Article Cell Biology

Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma

Ji-yan Xie et al.

CELL COMMUNICATION AND SIGNALING (2020)

Review Cell Biology

Strategies to inhibit arsenic trioxide-induced cardiotoxicity in acute promyelocytic leukemia

Habib Haybar et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Oncology

The Role of Angiogenesis in Hepatocellular Carcinoma

Michael A. Morse et al.

CLINICAL CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/Akt/HIF-1α signals

Jun Wan et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2016)

Review Public, Environmental & Occupational Health

ARSENIC - POISON OR MEDICINE?

Karolina Kulik-Kupka et al.

MEDYCYNA PRACY (2016)

Review Oncology

Angiopoietins in angiogenesis

Ernesta Fagiani et al.

CANCER LETTERS (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Effects of Arsenic Trioxide on Radiofrequency Ablation of VX2 Liver Tumor: Intraarterial versus Intravenous Administration

Nak Jong Seong et al.

KOREAN JOURNAL OF RADIOLOGY (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models

Andrew Hines-Peralta et al.

RADIOLOGY (2006)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model

C Horkan et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2004)